U.S. scientists have bioengineered bone marrow-derived stem cells to enable them to directly deliver a cancer-killing protein called TNF-related apoptosis-inducing ligand to tumors. Studies on mice and cell cultures showed that the cells proved effective in targeting various types of cancer cells without causing harm to healthy tissues.

Full Story:

Related Summaries